Get the Stockscreener App
0.0067
46.83%
-0.0138
Ocean Biomedical Inc stock is traded at $0.0067, with a volume of 1.70M.
It is down -46.83% in the last 24 hours and down -82.86% over the past month.
See More
Previous Close:
$0.0205
Open:
$0.0063
24h Volume:
1.70M
Relative Volume:
66.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-82.19M
P/E Ratio:
-0.00216
EPS:
-3.0969
Net Cash Flow:
$-8.35M
1W Performance:
-46.83%
1M Performance:
-82.86%
6M Performance:
-98.75%
1Y Performance:
-99.22%
1-Day Range:
$0.0059
$0.0067
1-Week Range:
$0.0059
$0.0067
52-Week Range:
$0.0059
$0.0067
Ocean Biomedical Inc Stock (OCEA) Company Profile
Compare OCEA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCEA
Ocean Biomedical Inc
|
0.0067 | 0 | 0 | -82.19M | -8.35M | -3.0969 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Ocean Biomedical Inc Stock (OCEA) Latest News
SEC filing of the week: Ocean Biomedical posts $8.42M loss in Q1 - Providence Business News
Sidoti Events, LLC's Virtual June Small-Cap Conference - The Globe and Mail
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - Voice of Alexandria
Ocean Biomedical, Inc. SEC 10-Q Report - TradingView
Dr. Chirinjeev Kathuria - Smart Business Dealmakers
Ocean Biomedical (NASDAQ: OCEA) Announces $1 Million Falk Award for Malaria Drug Candidate Addressing Evolving Resistance to Artemisinin-Based Therapeutics to Chief Scientist Dr. Jonathan Kurtis - Seeking Alpha
Ocean Biomedical stock plunges to 52-week low of $0.28 - MSN
SEC filing of the week: Ocean Biomedical expands into energy, digital assets; delisted from Nasdaq - Providence Business News
United States shares higher at close of trade; Dow Jones Industrial Average up 1.07% - Investing.com India
Brown spinoff Ocean Biomedical, knocked off the Nasdaq, becomes a 'crypto and energy' company - The Business Journals
Ocean Biomedical expands into energy and crypto sectors - Investing.com Australia
why Ocean Biomedical Inc [OCEA] is a Good Choice for Investors After New Price Target of $18.50 - dbtnews.com
Ocean Biomedical expands into energy and crypto sectors By Investing.com - Investing.com South Africa
Ocean Biomedical Inc: Weathering Stock Market Storms with 6.06M Market Cap - investchronicle.com
Ocean Biomedical (OCEA) Expands into Power Infrastructure and Crypto - GuruFocus
Ocean Biomedical (OCEA) Diversifies into Power and Cryptocurrency Sectors | OCEA Stock News - GuruFocus
Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value - The Manila Times
Ocean Biomedical Reveals Dramatic Business Transformation: Biotech Giant Expands into Energy and Digital Assets - Stock Titan
Ocean Biomedical Delays Yearly Report Filing - MSN
Ocean Biomedical stock plunges to 52-week low of $0.04 - Investing.com
Ocean Biomedical stock plunges to 52-week low of $0.04 By Investing.com - Investing.com Canada
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decrease in Short Interest - Defense World
Troubled Brown spinoff Ocean Biomedical racked up more losses in 2024 - The Business Journals
SEC filing of the week: Ocean Biomedical’s loss narrows to $9.4M in 2024 - Providence Business News
Ocean Biomedical, Inc. SEC 10-K Report - TradingView
Ocean Biomedical stock plunges to 52-week low of $0.05 - Investing.com
Ocean Biomedical stock plunges to 52-week low of $0.05 By Investing.com - Investing.com South Africa
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decline in Short Interest - Defense World
New CEO, several board members to step down from Ocean Biomedical - Providence Business News
Ocean Biomedical secures key patent in China for cancer therapy By Investing.com - Investing.com South Africa
Ocean Biomedical secures key patent in China for cancer therapy - Investing.com
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China - The Manila Times
Ocean Biomedical Announces Grant on Patent Right - GlobeNewswire
Revolutionary Cancer Treatment Patent Secured: Dual-Target Antibody Breaks Ground in Chinese Market - Stock Titan
Four board members to exit troubled RI biotechProvidence Business First - The Business Journals
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Ocean Biomedical slashes conversion price on investor note By Investing.com - Investing.com Australia
Ocean Biomedical stock plunges to 52-week low of $0.07 By Investing.com - Investing.com Australia
Ocean Biomedical stock plunges to 52-week low of $0.07 - Investing.com
Ocean Biomedical announces board reshuffle amid resignations By Investing.com - Investing.com Australia
Ocean Biomedical announces board reshuffle amid resignations - Investing.com
Ocean Biomedical issues Series A preferred stock - Investing.com India
Ocean Biomedical issues Series A preferred stock By Investing.com - Investing.com South Africa
Ocean Biomedical Inc Stock (OCEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.89%
3.74%
Cap:
|
Volume (24h):